Clinical Trial: Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07560358) titled 'Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer' on April 24.

Brief Summary: This is a randomized, controlled, multicenter clinical study that enrolled patients with unresectable bulky stage III NSCLC, with PFS as the primary endpoint. The study aims to investigate the efficacy and safety of adebrelimab combined with chemoradiotherapy in the treatment of locally advanced/unresectable stage III non-small cell lung cancer.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: NSCLC (Advanced Non-small Cell Lung Cancer)

Intervention: DRUG: After che...